Faculty

Anna Wald

Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Professor, Laboratory Medicine and Pathology
Division Head, Allergy & Infectious Diseases, Medicine - Allergy and Infectious Dis.

206-520-4340

Education

MD Medicine, Mt Sinai School of Medicine, 1985
MPH Epidemiology, University of Washington, 1994
BA Comparative Religion, Wesleyan University, 1979

Contact

206-520-4340

University of Washington
Box 359928
325 9th Avenue
Seattle, WA 98104

Research Areas

Research Interests

Dr. Wald's current research centers on the epidemiology and natural history of chronic viral infections in immunocompetent and immunocompromised hosts. She is also working on clinical trials of antiviral therapeutics and prophylactic and therapeutic vaccines for viral pathogens. Other ongoing studies address the interaction between sexually transmitted infections and microbiome.

Recent Publications (PubMed)

The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adults.
(2026 Feb 24)
Vaccine 77(): 128358
Whitaker JA, Rebolledo PA, Abate G, Babu TM, Rouphael NG, Wald A, El Sahly HM, Jooss K, Hart MG, Makowski M, Mu J, Carmack A, Archer JI, Roberts PC, Makhene M, Posavad CM, McElrath MJ, De Rosa SC, Coler R, Montefiori D, Eaton A, Suthar MS, Atmar RL, Hoft DF, DMID 20-0034 Study Team
Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): A randomized, double-blind, placebo-controlled trial.
(2026 Feb 13)
Int J Cancer
Stankiewicz Karita HC, Magaret AS, Doody DR, Schouten JT, Mao C, Huh WK, Grieco VS, Seymour MA, Varon D, Shrader KH, Xi LF, Galloway DA, Wald A, Madeleine MM
Herpes Simplex Virus Type 2 Screening in Persons with and Without HIV: Evidence, Challenges, and Future Directions.
(2026 Feb 2)
Curr HIV/AIDS Rep 23(1): 3
Abu-Raddad LJ, Chemaitelly H, Wald A, Johnston C
Herpes simplex virus type 1 and type 2 Western Blot serology test results from 1999-2020 in a US reference laboratory.
(2025 Dec 11)
Sex Transm Dis
Hussein A, Fischer M, Valinetz E, Pergam SA, Selke S, Pepper G, Jerome KR, Greninger AL, Wald A, Johnston C
Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents.
(2025 Oct 16)
Nat Commun 16(1): 9200
Ellison ST, Hayman I, Derr K, Derr P, Frebert S, Itkin Z, Shen M, Jones A, Olson W, Corey L, Wald A, Johnston C, Fong Y, Ferrer M, Zhu J
Show complete publication list